Trial intelligence / Profile preview

Anricofen Combined With Ciprofol for Deep Sedation in Elderly ERCP Patients

NCT07376577Recruiting

Sponsor
Xinxiang Medical University First Affiliated Hospital
Start
Jan 2026
Primary completion
Mar 2028
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tagileridine in sedation (3 arms), sponsored by Xinxiang Medical University First Affiliated Hospital. Primary endpoints: Intraoperative Pain Control Success Rate and Incidence of respiratory depression. Started Jan 2026; status: recruiting.

02

Drugs

tagileridine
03

Conditions

sedation

Beyond the preview

Go deeper on NCT07376577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07376577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call